tiprankstipranks
Trending News
More News >
ImageneBio (IMA)
NASDAQ:IMA
US Market
Advertisement

ImageneBio (IMA) Income Statement

Compare
106 Followers

ImageneBio Income Statement

Last quarter (Q2 2025), ImageneBio's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, ImageneBio's net income was $-2.77M. See ImageneBio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 9.16M$ 15.62M$ 30.98M$ 9.19M
Gross Profit
$ -490.00K$ 8.14M$ 13.58M$ -16.12M$ -35.65M
Operating Expenses
$ 54.06M$ 83.56M$ 84.49M$ 18.02M$ 8.87M
Depreciation and Amortization
$ 490.00K$ 1.02M$ 751.00K$ 544.00K$ 300.00K
EBITDA
$ -48.59M$ -74.40M$ -70.15M$ -33.59M$ -44.22M
Operating Income
$ -58.97M$ -75.42M$ -70.90M$ -34.14M$ -44.52M
Other Income/Expenses
$ 9.89M$ 7.09M$ 2.14M$ 23.00K$ 263.00K
Pretax Income
$ -49.08M$ -68.33M$ -68.77M$ -34.12M$ -44.26M
Net Income
$ -49.23M$ -68.17M$ -68.77M$ -34.12M$ -44.26M
Per Share Metrics
Basic EPS
$ -1.02$ -1.63$ -1.90$ -0.95$ -1.23
Diluted EPS
$ -1.02$ -1.63$ -1.90$ -0.95$ -1.23
Weighted Average Shares Outstanding
48.26M 41.74M 36.19M 35.98M 35.85M
Weighted Average Shares Outstanding (Diluted)
48.26M 41.74M 36.19M 35.98M 35.85M
Currency in USD

ImageneBio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis